A Promising Paradigm Shift in Cancer Treatment with FGFR Inhibitors

Area of Science:

• Medicinal Chemistry
• Oncology
• Pharmacology

Background:

• Fibroblast growth factor receptors (FGFRs) play a critical role in biological processes.
• FGFR overexpression is linked to the occurrence and progression of various carcinomas.
• FGFR inhibitors are gaining prominence in cancer research.

Purpose of the Study:

• To review recent advances in the structure-activity relationship (SAR) of FGFR inhibitors.
• To highlight diverse pharmacophores used in developing FGFR inhibitors.
• To provide insights into future research directions in FGFR inhibitor development.

Main Methods:

• Literature review focusing on FGFR inhibitors developed in the last five years.
• Analysis of SAR studies for various FGFR inhibitor derivatives.
• Presentation of representative examples including Naphthyl, Pyrimidine, Pyridazine, Indole, and Quinoline derivatives.

Main Results:

• FGFR inhibitors are essential tools for overcoming drug resistance, inhibiting tumor growth, and blocking angiogenesis.
• Structurally diverse FGFR inhibitors have been developed using various pharmacophores.
• Significant progress has been made in understanding the SAR of FGFR inhibitors.

Conclusions:

• FGFR inhibitors represent a promising therapeutic strategy for various cancers.
• Continued SAR studies are vital for discovering novel and more effective FGFR inhibitors.
• This field offers substantial future scope for medicinal chemists to achieve therapeutic breakthroughs.